Andrx Expects Concerta "Authorized" Generic From J&J's Patriot Unit, Third Party
This article was originally published in The Pink Sheet Daily
Executive Summary
In a citizen petition, Andrx requests FDA re-evaluate its policy concerning the marketing of "authorized" generic versions of brand drugs. Petition urges the agency to seek formal input from FTC and Justice Department on potential anticompetitive effects.